Temporal patterns of drug‐eluting stent failure and its relationship with clinical outcomes
暂无分享,去创建一个
Seung‐Jung Park | Young-Hak Kim | Duk‐Woo Park | Jung‐Min Ahn | Cheol-Whan Lee | Seung‐Whan Lee | Soo-Jin Kang | Seong-Wook Park | Jong-Young Lee | S. Yoon | Sung-Han Yoon | Seung-Jung Park
[1] M. Kimura,et al. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study. , 2013, European heart journal cardiovascular Imaging.
[2] A. Kastrati,et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial , 2013, The Lancet.
[3] Soo-Jin Kang,et al. In-stent neoatherosclerosis: a final common pathway of late stent failure. , 2012, Journal of the American College of Cardiology.
[4] I. Seong,et al. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation. , 2012, Journal of the American College of Cardiology.
[5] Seung‐Jung Park,et al. Optical Coherence Tomographic Analysis of In-Stent Neoatherosclerosis After Drug–Eluting Stent Implantation , 2011, Circulation.
[6] F. Eberli,et al. Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents: Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial , 2011, Circulation.
[7] M. Kimura,et al. Difference of Tissue Characteristics Between Early and Very Late Restenosis Lesions After Bare-Metal Stent Implantation: An Optical Coherence Tomography Study , 2011, Circulation. Cardiovascular interventions.
[8] Masataka Nakano,et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. , 2011, Journal of the American College of Cardiology.
[9] Seung‐Jung Park,et al. Mechanisms of In-Stent Restenosis After Drug-Eluting Stent Implantation: Intravascular Ultrasound Analysis , 2011, Circulation. Cardiovascular interventions.
[10] Seung‐Jung Park,et al. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. , 2010, The American journal of cardiology.
[11] P. Serruys,et al. Coronary stents: current status. , 2010, Journal of the American College of Cardiology.
[12] Y. Hayashi,et al. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). , 2010, The American journal of cardiology.
[13] Seung‐Jung Park,et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. , 2010, Journal of the American College of Cardiology.
[14] G. Lemesle,et al. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. , 2009, Archives of cardiovascular diseases.
[15] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[16] S. Markwell,et al. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. , 2007, Journal of the American College of Cardiology.
[17] A. Colombo,et al. Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents. , 2006, European heart journal.
[18] G. Biondi-Zoccai,et al. Drug-eluting stent restenosis the pattern predicts the outcome. , 2006, Journal of the American College of Cardiology.
[19] Deepak L. Bhatt,et al. Bare metal stent restenosis is not a benign clinical entity. , 2006, American heart journal.
[20] Seung‐Jung Park,et al. Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries. , 2006, American Journal of Cardiology.
[21] A. Kastrati,et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. , 2005, JAMA.
[22] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[23] S. Silber,et al. Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions , 2003, Circulation.
[24] R. Choussat,et al. In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. , 2000, Journal of the American College of Cardiology.
[25] G. Stone,et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.
[26] J. Alpert,et al. The third universal definition of myocardial infarction , 2013 .
[27] Ousa,et al. A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION , 2002 .